Shaily Engineering Plastics Limited announced a robust financial performance for the fiscal year ended March 31, 2026. Revenue surged by 25.91% to ₹990.67 crore, driven by strong momentum in its key growth businesses, particularly Healthcare. EBITDA also saw significant growth, increasing by 61.28% to ₹287.7 crore, with a notable expansion in EBITDA margin to 29.0%. The company’s net profit grew by 82.5% to ₹169.91 crore.
Strong Financial Performance in FY 2025-26
Shaily Engineering Plastics Limited has reported a significant year of growth for the fiscal year ended March 31, 2026. The company’s strategic investments in capabilities and infrastructure have translated into strong financial performance, demonstrating improved operating leverage and profitability.
Key Financial Highlights
The company’s revenue grew by 25.91% year-on-year, reaching ₹990.67 crore. This growth was primarily fueled by strong momentum across its key business segments, with a particular emphasis on the Healthcare sector, which experienced a remarkable 139% increase in revenue. EBITDA more than doubled, growing by 61.28% to ₹287.7 crore, leading to an expanded EBITDA margin of 29.0%. Net profit saw a substantial increase of 82.5%, reaching ₹169.91 crore. Capital efficiency also improved significantly, with ROCE expanding by 1,140 basis points to 35.8%.
Healthcare as a Growth Engine
The Healthcare segment emerged as the most transformative driver of the company’s business in FY 2025-26. Its revenue contribution rose significantly, accounting for approximately 40% of consolidated revenue, up from around 21% in the previous year. This growth is attributed to the structural transformation in drug delivery, with a shift towards self-administration and the increasing demand for sophisticated delivery devices, creating a long-term, high-entry barrier opportunity.
Strategic Outlook
Shaily Engineering Plastics is well-positioned for future growth, with a focus on expanding its capabilities in precision manufacturing and strengthening its global presence. The company’s disciplined capital allocation and commitment to innovation are expected to drive sustained shareholder value and further enhance its competitive advantage.
Source: BSE
